Controversies in stable coronary artery disease
- 1 January 2006
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 367 (9504) , 69-78
- https://doi.org/10.1016/s0140-6736(06)67927-0
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trialPublished by Elsevier ,2005
- Exercise Prescription and Proscription for Patients With Coronary Artery DiseaseCirculation, 2005
- Increased Cardiovascular Morbidity and Mortality in Type 2 Diabetes Is Associated With the Glutathione S Transferase Theta–Null GenotypeCirculation, 2005
- Vascular and Metabolic Effects of Combined Therapy With Ramipril and Simvastatin in Patients With Type 2 DiabetesHypertension, 2005
- ACE Inhibition in Stable Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: Efficacy and safety of ezetimibe co-administered with atorvastatinAmerican Heart Journal, 2004
- Long-term outcomes of optimized medical management of outpatients with stable coronary artery diseaseThe American Journal of Cardiology, 2004
- A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomesJournal of the American College of Cardiology, 2003
- Cardiovascular disease risk profilesAmerican Heart Journal, 1991